DE602005006547D1 - Entzündungshemmende lactone - Google Patents

Entzündungshemmende lactone

Info

Publication number
DE602005006547D1
DE602005006547D1 DE602005006547T DE602005006547T DE602005006547D1 DE 602005006547 D1 DE602005006547 D1 DE 602005006547D1 DE 602005006547 T DE602005006547 T DE 602005006547T DE 602005006547 T DE602005006547 T DE 602005006547T DE 602005006547 D1 DE602005006547 D1 DE 602005006547D1
Authority
DE
Germany
Prior art keywords
lactone
inflammatory
lactones
inflammation
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE602005006547T
Other languages
English (en)
Inventor
Josef Gottfried Meingassner
Klaus Thirring
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0407466A external-priority patent/GB0407466D0/en
Priority claimed from GB0407467A external-priority patent/GB0407467D0/en
Application filed by Novartis AG filed Critical Novartis AG
Publication of DE602005006547D1 publication Critical patent/DE602005006547D1/de
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE602005006547T 2004-04-01 2005-03-31 Entzündungshemmende lactone Expired - Fee Related DE602005006547D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0407466A GB0407466D0 (en) 2004-04-01 2004-04-01 Organic compounds
GB0407467A GB0407467D0 (en) 2004-04-01 2004-04-01 Organic compounds
PCT/EP2005/003384 WO2005097771A1 (en) 2004-04-01 2005-03-31 Antiinflammatory lactones

Publications (1)

Publication Number Publication Date
DE602005006547D1 true DE602005006547D1 (de) 2008-06-19

Family

ID=34966979

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005006547T Expired - Fee Related DE602005006547D1 (de) 2004-04-01 2005-03-31 Entzündungshemmende lactone

Country Status (14)

Country Link
US (1) US7414074B2 (de)
EP (1) EP1735295B1 (de)
JP (1) JP2007530630A (de)
KR (1) KR20070015529A (de)
AT (1) ATE394385T1 (de)
AU (1) AU2005231939B2 (de)
BR (1) BRPI0509494A (de)
CA (1) CA2558244A1 (de)
DE (1) DE602005006547D1 (de)
ES (1) ES2303245T3 (de)
PL (1) PL1735295T3 (de)
PT (1) PT1735295E (de)
RU (1) RU2006138429A (de)
WO (1) WO2005097771A1 (de)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH666482A5 (de) * 1984-02-08 1988-07-29 Sandoz Ag Metabolit, dessen herstellung und verwendung.
JP2002047281A (ja) * 2000-07-28 2002-02-12 Mitsubishi-Tokyo Pharmaceuticals Inc テロメレース阻害剤

Also Published As

Publication number Publication date
CA2558244A1 (en) 2005-10-20
US7414074B2 (en) 2008-08-19
AU2005231939A1 (en) 2005-10-20
EP1735295B1 (de) 2008-05-07
EP1735295A1 (de) 2006-12-27
PT1735295E (pt) 2008-06-23
WO2005097771A1 (en) 2005-10-20
JP2007530630A (ja) 2007-11-01
AU2005231939B2 (en) 2008-05-22
PL1735295T3 (pl) 2008-10-31
BRPI0509494A (pt) 2007-09-11
ATE394385T1 (de) 2008-05-15
KR20070015529A (ko) 2007-02-05
ES2303245T3 (es) 2008-08-01
US20070219143A1 (en) 2007-09-20
RU2006138429A (ru) 2008-05-10

Similar Documents

Publication Publication Date Title
UY30500A1 (es) Compuestos de azabencimidazolilo
BRPI0917017B8 (pt) inibidores de pirrol de s-nitrosoglutationa redutase como agentes terapêuticos
CR20110131A (es) Derivados de prostaglandinas
NO20071617L (no) Indozolonderivater som 11B-HSD1-inhibitorer
NO20083630L (no) Nye pyridinderivater
NO20090434L (no) Heteroarylforbindelser anvendbare som inhibitorer av E1-aktiverende enzymer
CY2014012I1 (el) Χορηγηση αναστολεων διπεπτιδυλοπεπτιδασης
UY29170A1 (es) Adeninas sustituidas y usos de las mismas
UA112425C2 (uk) ЗАМІЩЕНІ N-(1H-ІНДАЗОЛ-4-ІЛ)ІМІДАЗО[1,2-a]ПІРИДИН-3-КАРБОКСАМІДНІ СПОЛУКИ ЯК ІНГІБІТОРИ РЕЦЕПТОРНОЇ ТИРОЗИНКІНАЗИ ІІІ ТИПУ
EA200801784A1 (ru) Ингибиторы е1 активирующих ферментов
NO20091395L (no) Nye tiofenderivater
NO20083726L (no) Spiroindolinon derivater
UY29238A1 (es) Formulaciones de nepafenac para su administracion topica
ECSP088456A (es) Derivados de [4-(benzo[b]tiofen-2-il)pirimidn-2il]-amina como inhibidores ikk-beta para el tratamiento de cancer y enfermedades inflamatorias
CO5700775A2 (es) Nuevos derivados triciclicos como antagonistas de ltd4
ATE552336T1 (de) Herstellung biologisch aktiver proteine
ECSP066693A (es) Derivados de bencimidazol
RS53617B1 (en) NEW UNITS USEFUL FOR TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES
NO20080554L (no) Pyrazolonderivater
FR2873585B1 (fr) Nouvelles formulations galeniques de principes actifs
ECSP056006A (es) Composiciones farmacéuticas que comprenden una combinación de rapamicina o su derivado y pimecrolimus para el tratamiento de enfermedades inflamatorias e inmunológicamente mediadas
CY1109992T1 (el) Παραγωγα του αλφα-αμιναμιδιου χρησιμα ως αντιφλεγμονωδη μεσα
DK1798234T3 (da) Farmaceutisk sammensætning omfattende temozolomidester
ATE427315T1 (de) Neue makrolide
EA200601368A1 (ru) Макролиды, обладающие противовоспалительной активностью

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336

R082 Change of representative

Ref document number: 1735295

Country of ref document: EP

Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN, DE

R119 Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal fee

Ref document number: 1735295

Country of ref document: EP

Effective date: 20111001